Advertisement

The need for “made in Canada” glaucoma epidemiology data

      Our understanding of risk factors contributing to the development of glaucoma continues to improve. New technology to assist in diagnosing glaucoma continues to evolve. Effective treatment for glaucoma is readily available, especially in industrialized countries. Nonetheless, glaucoma remains the second leading cause of blindness after cataract and the leading cause of irreversible blindness worldwide.
      • Resnikoff S.
      • Pascolini D.
      • Etya'ale D.
      • et al.
      Global data on visual impairment in the year 2002.
      It is estimated that in 2010, 60.5 million people worldwide will have glaucoma and 8.4 million will be bilaterally blind because of the disease,
      • Quigley H.A.
      • Broman A.T.
      The number of people with glaucoma worldwide in 2010 and 2020.
      but what do we know about the burden of glaucoma in Canada, and how accurate is that information?
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Canadian Journal of Ophthalmology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Resnikoff S.
        • Pascolini D.
        • Etya'ale D.
        • et al.
        Global data on visual impairment in the year 2002.
        Bull World Health Organ. 2004; 82: 844-851
        • Quigley H.A.
        • Broman A.T.
        The number of people with glaucoma worldwide in 2010 and 2020.
        Br J Ophthalmol. 2006; 90: 262-267
        • Shenken E.
        The Scarborough Glaucoma Survey.
        Can Med Assoc J. 1966; 95: 595-602
        • Sommer A.
        • Tielsch J.M.
        • Katz J.
        • et al.
        Relationship between intraocular pressure and primary open-angle glaucoma among white and black Americans: The Baltimore Eye Survey.
        Arch Ophthalmol. 1991; 109: 1090-1095
        • Coffey M.
        • Reidy A.
        • Wormald R.
        • et al.
        Prevalence of glaucoma in the west of Ireland.
        Br J Ophthalmol. 1993; 77: 17-21
        • Mitchell P.
        • Smith W.
        • Attebo K.
        • Healey P.R.
        Prevalence of open-angle glaucoma in Australia—The Blue Mountains Eye Study.
        Ophthalmology. 1996; 103: 1661-1669
        • Perruccio A.V.
        • Badley E.M.
        • Trope G.E.
        Self-reported glaucoma in Canada: findings from population-based surveys, 1994-2003.
        Can J Ophthalmol. 2007; 42 (219-16)
        • Anraku A.
        • Jin Y.P.
        • Butty Z.
        • Trope G.E.
        • et al.
        The Toronto epidemiology glaucoma survey: a pilot study.
        Can J Ophthalmol. 2011; xx (xx-xx)
        • Coffey M.
        • Reidy A.
        • Wormald R.
        • et al.
        Prevalence of glaucoma in the west of Ireland.
        Br J Ophthalmol. 1993; 77: 17-21
        • MacKean J.M.
        • Elkington A.R.
        Referral routes to hospital of patients with chronic open-angle glaucoma.
        Br Med J (Clin Res Ed). 1982; 285: 1093-1095
        • Sheldrick J.H.
        • Ng C.
        • Austin D.J.
        An analysis of referral routes and diagnostic accuracy in cases of suspected glaucoma.
        Ophthal Epidemiol. 1994; 1: 31-39
        • Ng W.S.
        • Agarwal P.K.
        • Sidiki S.
        • et al.
        The effect of socio-economic deprivation on severity of glaucoma at presentation.
        Br J Ophthalmol. 2010; 94: 85-87
        • Hattenhauer M.G.
        • Johnson D.H.
        • Ing H.H.
        • et al.
        The probability of blindness from open-angle glaucoma.
        Ophthalmology. 1998; 105: 2099-2104
        • Iskedjian M.
        • Walker J.
        • Vicente C.
        • et al.
        Cost of glaucoma in Canada: analysis based on visual field and physician's assessment.
        J Glaucoma. 2003; 12: 456-462
        • Noe G.
        • Ferraro J.
        • Lamoureux E.
        • et al.
        Associations between glaucomatous visual field loss and participation in activities of daily living.
        Clin Exper Ophthalmol. 2003; 31: 482-486
        • Altangerel U.
        • Spaeth G.L.
        • Rhee D.J.
        Visual function, disability, and psychological impact of glaucoma.
        Curr Opin Ophthalmol. 2003; 14: 100-105
        • Haymes S.A.
        • Leblanc R.P.
        • Nicolela M.T.
        • et al.
        Risk of falls and motor vehicle collisions in glaucoma.
        Invest Ophthalmol Vis Sci. 2007; 48: 1149-1155
        • Rafuse P.E.
        • Buys Y.M.
        • Damji K.F.
        • et al.
        Canadian Ophthalmological Society evidence-based clinical practice guidelines for the management of glaucoma in the adult eye.
        Can J Ophthalmol. 2009; 44: S7-S93
        • Rudnicka A.R.
        • Mt-Isa R.
        • Owen C.G.
        • et al.
        Variations in primary open-angle glaucoma prevalence by age, gender, and race: a Bayesian meta-analysis.
        Invest Ophthalmol Vis Sci. 2006; 47: 4254-4261
        • Buhrmann R.
        • Hodge W.
        • Beardmore M.A.
        Foundations for a Canadian vision-health strategy: towards preventing avoidable blindness and promotion vision health.
        (Accessed March 13, 2011)
        • Pascolini D.
        • Mariotti S.P.
        • Pokharel G.P.
        • et al.
        2002 global update of available data on visual impairment: a compilation of population-based prevalence studies.
        Ophthal Epidemiol. 2004; 11: 67-115

      Références